Drug-eluting bioresorbable stents for various applications
- PMID: 16834554
- DOI: 10.1146/annurev.bioeng.8.013106.151418
Drug-eluting bioresorbable stents for various applications
Abstract
A stent is a medical device designed to serve as a temporary or permanent internal scaffold to maintain or increase the lumen of a body conduit. Metallic coronary stents were first introduced to prevent arterial dissections and to eliminate vessel recoil and intimal hyperplasia associated with percutaneous transluminal coronary angioplasty. The stent application range has expanded as more experience was gained, and encouraging results have been obtained in the treatment of vascular diseases. Stents are currently used for support of additional body conduits, including the urethra, trachea, and esophagus. The rationale for bioresorbable stents is the support of a body conduit only during its healing process. The stent mass and strength decrease with time, and the mechanical load is gradually transferred to the surrounding tissue. Bioresorbable stents also enable longer term delivery of drugs to the conduit wall from an internal reservoir and abolish the need for a second surgery to remove the device. The present review describes recent advances in bioresorbable stents, focusing on drug-eluting bioresorbable stents for various applications. Controlled release of an active agent from a stent can be used to enhance healing of the surrounding tissues, to increase the implant's biocompatibility, as well as to help cure certain diseases. Because a lot of research in this field has been done by us, examples for these functions are described based mainly on developments in our laboratories.
Similar articles
-
Approaches for prevention of restenosis.J Biomed Mater Res B Appl Biomater. 2008 May;85(2):583-603. doi: 10.1002/jbm.b.30974. J Biomed Mater Res B Appl Biomater. 2008. PMID: 18098192 Review.
-
[The bioresorbable coronary scaffold].Ned Tijdschr Geneeskd. 2012;156(36):A4994. Ned Tijdschr Geneeskd. 2012. PMID: 22951133 Dutch.
-
Polymers, drug release, and drug-eluting stents.J Interv Cardiol. 2006 Dec;19(6):500-6. doi: 10.1111/j.1540-8183.2006.00198.x. J Interv Cardiol. 2006. PMID: 17107364 Review.
-
Engineering aspects of stents design and their translation into clinical practice.Ann Ist Super Sanita. 2007;43(1):89-100. Ann Ist Super Sanita. 2007. PMID: 17536159 Review.
-
Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.Expert Rev Med Devices. 2014 Sep;11(5):467-80. doi: 10.1586/17434440.2014.941812. Epub 2014 Aug 2. Expert Rev Med Devices. 2014. PMID: 25087771 Review.
Cited by
-
EGCG Regulates Cell Apoptosis of Human Umbilical Vein Endothelial Cells Grown on 316L Stainless Steel for Stent Implantation.Drug Des Devel Ther. 2021 Feb 11;15:493-499. doi: 10.2147/DDDT.S296548. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33603339 Free PMC article.
-
Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT.Health Technol Assess. 2020 Nov;24(61):1-110. doi: 10.3310/hta24610. Health Technol Assess. 2020. PMID: 33228846 Free PMC article. Clinical Trial.
-
The Real Need for Regenerative Medicine in the Future of Congenital Heart Disease Treatment.Biomedicines. 2021 Apr 27;9(5):478. doi: 10.3390/biomedicines9050478. Biomedicines. 2021. PMID: 33925558 Free PMC article. Review.
-
Scattering integral equation formulation for intravascular inclusion biosensing.Sci Rep. 2024 Jul 1;14(1):14978. doi: 10.1038/s41598-024-64633-0. Sci Rep. 2024. PMID: 38951563 Free PMC article.
-
Fabrication and in vitro deployment of a laser-activated shape memory polymer vascular stent.Biomed Eng Online. 2007 Nov 27;6:43. doi: 10.1186/1475-925X-6-43. Biomed Eng Online. 2007. PMID: 18042294 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources